Avant Bio Fund II LP
Avant Bio Fund II LP is a venture capital fund based in New York, New York. According to its most recent Form D, filed Dec 23, 2024, it has sold $57,450,000 of interests to 12 investors since its first sale in May 2023. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Daniella Kranjac.
- Total raised
- $57,450,000Cumulative sales reported on Form D
- Investors
- 12
- First sale
- May 12, 2023
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Daniella Kranjac
- Latest Form D
- Dec 23, 2024
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Dec 23, 2024 | Form D/A (amendment) | $57,450,000 | 12 | SEC.gov ↗ |
| Aug 18, 2023 | Form D | $36,950,000 | 10 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Aug 18, 2023. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Avant Bio Fund II LP
What is the minimum investment for Avant Bio Fund II LP?
Avant Bio Fund II LP's latest Form D, filed Dec 23, 2024, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Avant Bio Fund II LP?
Avant Bio Fund II LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Avant Bio Fund II LP raised?
Avant Bio Fund II LP reports $57,450,000 sold from 12 investors on its Form D filed Dec 23, 2024. This is cumulative sales since the offering began, not current assets or performance.
Where is Avant Bio Fund II LP based?
Avant Bio Fund II LP is based in New York, New York and is managed by Avant Bio LLC.
When did Avant Bio Fund II LP launch?
Avant Bio Fund II LP reports its first sale in May 2023.
Size compared with every venture capital fund
Raised more than 93% of the 1,243 venture capital funds based in New York, and more than 97% of all 14,876 that report sales.